Clinical Trial Update: Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical study of VG161 in combination with nivolumab in advanced pancreatic cancer across Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• VG161
• nivolumab (nivolumab)

Snippet

Sponsor: Zhejiang University | Conditions: Advanced Pancreatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN